Man Group plc Invests $5.70 Million in Chemed Corporation $CHE

Man Group plc bought a new position in shares of Chemed Corporation (NYSE:CHE) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 12,232 shares of the company’s stock, valued at approximately $5,697,000. Man Group plc owned about 0.09% of Chemed as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Northwestern Mutual Wealth Management Co. raised its position in shares of Chemed by 2,444,879.3% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock worth $2,374,667,000 after acquiring an additional 5,549,876 shares in the last quarter. BlackRock Inc. bought a new stake in shares of Chemed during the 2nd quarter valued at about $691,290,000. JPMorgan Chase & Co. boosted its position in shares of Chemed by 4.4% during the 4th quarter. JPMorgan Chase & Co. now owns 521,900 shares of the company’s stock valued at $223,301,000 after purchasing an additional 21,932 shares in the last quarter. AQR Capital Management LLC grew its stake in Chemed by 89.2% during the fourth quarter. AQR Capital Management LLC now owns 325,579 shares of the company’s stock worth $139,302,000 after purchasing an additional 153,469 shares during the period. Finally, TD Asset Management Inc grew its stake in Chemed by 7.5% during the fourth quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock worth $138,860,000 after purchasing an additional 22,715 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insider Buying and Selling

In other Chemed news, Director Patrick P. Grace sold 190 shares of the firm’s stock in a transaction on Friday, July 31st. The stock was sold at an average price of $532.00, for a total transaction of $101,080.00. Following the transaction, the director directly owned 3,533 shares in the company, valued at approximately $1,879,556. This trade represents a 5.10% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Friday, August 21st. The stock was sold at an average price of $541.16, for a total transaction of $1,082,320.00. Following the transaction, the chief executive officer directly owned 70,418 shares in the company, valued at $38,107,404.88. This represents a 2.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 6,537 shares of company stock valued at $3,406,014. 3.33% of the stock is owned by corporate insiders.

Chemed Price Performance

CHE stock opened at $523.57 on Friday. The company has a market capitalization of $6.84 billion, a P/E ratio of 26.30, a price-to-earnings-growth ratio of 1.98 and a beta of 0.51. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91. Chemed Corporation has a 52-week low of $365.20 and a 52-week high of $557.00. The business has a 50-day simple moving average of $509.45 and a two-hundred day simple moving average of $449.67.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, topping analysts’ consensus estimates of $5.60 by $0.46. The firm had revenue of $673.25 million during the quarter, compared to analyst estimates of $665.04 million. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The company’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same period in the previous year, the company posted $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Research analysts expect that Chemed Corporation will post 23.18 EPS for the current fiscal year.

Chemed Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be given a $0.70 dividend. This represents a $2.80 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend is Monday, August 17th. This is an increase from Chemed’s previous quarterly dividend of $0.60. Chemed’s payout ratio is currently 14.06%.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on CHE shares. Bank of America restated a “neutral” rating on shares of Chemed in a research note on Wednesday, July 29th. Wall Street Zen raised Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. Royal Bank Of Canada increased their price target on Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a report on Thursday, July 30th. Weiss Ratings raised Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. Finally, Oppenheimer boosted their price objective on Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a report on Friday, July 31st. One equities research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Chemed presently has an average rating of “Hold” and an average target price of $530.75.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.